🇺🇸 nadroparin in United States

1,085 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 127 reports (11.71%)
  2. Dyspnoea — 127 reports (11.71%)
  3. Off Label Use — 126 reports (11.61%)
  4. Pneumonia — 123 reports (11.34%)
  5. Pyrexia — 120 reports (11.06%)
  6. Anaemia — 112 reports (10.32%)
  7. Drug Interaction — 104 reports (9.59%)
  8. Vomiting — 86 reports (7.93%)
  9. Hyponatraemia — 82 reports (7.56%)
  10. Maternal Exposure During Pregnancy — 78 reports (7.19%)

Source database →

nadroparin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United States

Frequently asked questions

Is nadroparin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for nadroparin in United States?

Onze Lieve Vrouwe Gasthuis is the originator. The local marketing authorisation holder may differ — check the official source linked above.